LEMIFLEMIF
LOADING
|||
R&D Expense Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
0.00%
↓ 100% below average
Average (39q)
77.89%
Historical baseline
Range
High:1070.35%
Low:-197.65%
Volatility
1627.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 122.85% |
| Q4 2024 | -197.65% |
| Q3 2024 | 198.02% |
| Q2 2024 | -19.88% |
| Q1 2024 | -47.29% |
| Q4 2023 | 1070.35% |
| Q3 2023 | -47.01% |
| Q2 2023 | -39.16% |
| Q1 2023 | 170.22% |
| Q4 2022 | -61.42% |
| Q3 2022 | 31.61% |
| Q2 2022 | 52.82% |
| Q1 2022 | -75.88% |
| Q4 2021 | -20.31% |
| Q3 2021 | 135.03% |
| Q2 2021 | -74.55% |
| Q1 2021 | 79.93% |
| Q4 2020 | 463.34% |
| Q3 2020 | 83.13% |
| Q2 2020 | -56.12% |
| Q1 2020 | -42.17% |
| Q4 2019 | -42.27% |
| Q3 2019 | -5.30% |
| Q2 2019 | -26.30% |
| Q1 2019 | -81.57% |
| Q4 2018 | 246.64% |
| Q3 2018 | 113.15% |
| Q2 2018 | -5.89% |
| Q1 2018 | -77.82% |
| Q4 2017 | 342.07% |
| Q3 2017 | 63.01% |
| Q2 2017 | -15.09% |
| Q1 2017 | 588.93% |
| Q4 2016 | 141.72% |
| Q3 2016 | 27.78% |
| Q2 2016 | 110.19% |
| Q1 2016 | -85.66% |
| Q4 2015 | 196.13% |